SU‐GG‐T‐71: Study of Dosimetric Variation Due to Interfraction Organ Movement in High Dose Rate Interstital (MUPIT) Brachytherapy for Gynecologic Malignancies

T. Velmurugan, S. Prabakar, C. Krishnappan, m. Janarthina Kani, B. Raghavendiran

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To study the dosimetric effects of inter‐fractional organ motion in HDR interstitial MUPIT brachytherapy application for gynaecologic malignancy. Methods & Materials: Ten patients with cancer of uterine cervix who underwent interstitial brachytherapy using MUPIT templates were selected. After implant, CT images were taken (CT1) using which bladder, rectum and CTV were delineated. The treatment plan PCT1 was generated and optimized geometrically on the volume. CT scan (CT2) was repeated before the second fraction of the treatment CTV and critical organs were delineated. The plan (PCT2) was created by reproducing the Plan PCT1 in the CT2 images. The inter‐fractional dosimetric variations between two fractions were estimated by comparing the PCT1 and PCT2. Result & Discussion: Bladder, Rectum and CTV percentage volume variation ranges from +28.6 % to −34.3%, 38.4% to −14.9% and 8.5% to −15.2% respectively. Maximum dose variation in bladder ranges from + 17.1 % to −66.2%,in rectum was up to 410% and in CTV was −13.0% in one patient and less than 1% in all other patients. Conclusions: The variations in volume observed from OAR and CTV are patient specific. Also, the dose to these structures varies independently with no strong correlation with the volume variation. Hence it is suggested that repeat CT and re‐planning is mandatory before second fraction execution.

Original languageEnglish (US)
Pages (from-to)3200
Number of pages1
JournalMedical Physics
Volume37
Issue number6
DOIs
StatePublished - Jun 2010
Externally publishedYes

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'SU‐GG‐T‐71: Study of Dosimetric Variation Due to Interfraction Organ Movement in High Dose Rate Interstital (MUPIT) Brachytherapy for Gynecologic Malignancies'. Together they form a unique fingerprint.

Cite this